Call for an instant quote 0345 90 80 161
Open Mon to Fri 09:00 - 17:30 | Sat 09:00 - 16:00 (GMT)
17 November 2017 09:18
It's estimated 8,000 women could benefit from the drugs
Women diagnosed with untreatable breast cancer are being given fresh hope, with the approval of two new "breakthrough" medicines for widespread use across England's health service.
The National Institute for Health and Care Excellence (Nice) has approved NHS use of palbociclib and ribociclib - drugs that are shown to slow down advance cancer and delay the need for chemotherapy.
Nice - which has rejected palbociclib in the past because of its high cost - has announced the new agreement after negotiating a new lower price with manufactured Pfizer.
A life-changing breakthrough
Around 45,000 women receive new diagnoses of breast cancer each year in England, and it's estimated 8,000 women could benefit from the ground-breaking treatment.
Nicholas Turner, trial lead and professor of molecular oncology at the Institute of Cancer Research (ICR) in London and consultant medical oncologist at the Royal Marsden, says: "The development of this brand new class of cancer drug is one of the most important breakthroughs for women with advanced breast cancer in the last two decades.
"In clinical trials, palbociclib and ribociclib have made a huge difference to women's lives - slowing down tumour growth for nearly a year, and delaying the need for chemotherapy with all its potentially debilitating side-effects. These drugs have allowed women to live a normal life for longer."
Treatment for women of any age
Women who are pre-menopausal and have been diagnosed with oestrogen receptor positive breast cancer after it the disease has spread will be eligible for palbociclib.
Post-menopausal women diagnosed who are diagnosed under the same conditions will be treated with ribociclib, manufactured by Novartis.
Both drugs work in a similar way, and are shown to hold back breast cancer for at least 10 months, affording women a normal life for longer.
Even if your cancer has spread, if you have had chemotherapy in the last three months, are taking strong painkillers or have a terminal prognosis, we may still be able to cover you for holidays and overseas travel with our specialist cancer travel insurance.
19 February 2019
Hundreds of passengers have had their travel plans cancelled following the collapse of airline flybmi.
[more...]
16 February 2019
Holidaymakers were left fuming after a "lack of clarity" over Brexit led a Romanian airline to cancel flights from Liverpool's John Lennon Airport.
15 February 2019
British Airways celebrated Valentine's Day with a special flight where all members of the cabin crew were couples who work for the airline.
14 February 2019
The "concerning" level of stigma surrounding the human papilloma virus (HPV) could be putting some women off going for vital check-ups, campaigners are warning.
13 February 2019
Older people living with depression should be given better access to community activities and therapy instead of being prescribed antidepressants, researchers have urged.
12 February 2019
The Government has been criticised for failing to act on warnings about the link between processed meats and cancer, by the scientist who co-authored the original advice.
09 February 2019
A grandfather who has battled three types of cancer is cycling from Twickenham to Tokyo in time for the Rugby World Cup - all in aid of charity.
08 February 2019
Lovers of traditional fish and chips are embracing a more health-conscious version of their favourite food, a new study suggests.
07 February 2019
Two thirds of UK adults don't know they're able to lower their risk of developing dementia, new research has shown.
06 February 2019
More than 600 people a day are quitting their jobs to care for relatives, a charity has warned.
05 February 2019
Millennials in the US face an increasing risk of developing an obesity-related cancer, a new study has revealed.
02 February 2019
More than 100 people sought refuge at a pub high on Bodmin Moor overnight after heavy snowfall hit the A30, leading many stranded motorists to abandon their cars.